Phase 3 Trial Linked to Terlipressin Use Marked Completed

On 2026-10-27, the trial registry ClinicalTrials.gov updated the status of a study titled "Bovine Colostrum In The Treatment Of Severe Alcohol-Associated Hepatitis" to completed. The trial, registered as NCT07898761, was conducted as a Phase 3 study. Terlipressin, an approved compound, is associated with this trial record. The update reflects a change in trial status only, as recorded in the registry entry dated 2026-10-27. No outcome data, efficacy findings, or safety conclusions were included in this status update. The registry entry confirms only that the study has reached completed status at the Phase 3 stage. Readers should note that a completed status indicates the trial has concluded enrollment and data collection phases, not that results have been published or reviewed. Further details on trial design, endpoints, or findings are not included in this update and would require review of the full registry record or subsequent publications. For additional context on terlipressin, including its approved regulatory status and general background, readers can consult the compound overview.